Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 6/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | SORD | Q00796 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL938025 | 1.00 | FDPS (0.38) | FDPSP2RX7SORDALDH1A1L3MBTL1 | |
| Pyrophosphoric Acid SCHEMBL459236 | 0.87 | FDPS (0.42) | FDPSP2RX7SORDALDH1A1L3MBTL1 | |
| Phosphoric Acid SCHEMBL28969998 | 0.78 | FDPS (0.37) | FDPSP2RX7 | |
| Pyridine SCHEMBL15552200 | 0.75 | NAPRT (0.45) | SORDALDH1A1L3MBTL1GAA | |
| SCHEMBL939997 | 0.75 | PGK1 (0.46) | FDPSP2RX7PGK1PGK2 | |
| Phosphoric Acid SCHEMBL28528859 | 0.72 | ALDH1A1 (0.50) | FDPSALDH1A1 | |
| Phosphoric Acid SCHEMBL28334069 | 0.72 | FDPS (0.39) | FDPSALDH1A1L3MBTL1 | |
| SCHEMBL16569729 | 0.72 | LMNA (0.41) | P2RX7SORDALDH1A1L3MBTL1 | |
| Phosphoric Acid SCHEMBL28095761 | 0.69 | FDPS (0.41) | FDPSP2RX7ALDH1A1 | |
| Phosphoric Acid SCHEMBL28192934 | 0.69 | HSP90AA1 (0.67) | FDPSP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | claimed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | claimed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | claimed |
| CN-117897476-A | Microbial cell factory for producing vitamin B compounds | 拜奥信尼亚私营有限责任公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024013212-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2024-01-18 | — | — | WO | claimed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | claimed |
| WO-2026099311-A2 | MICROBIAL CELL FACTORIES PRODUCING PROSTAGLANDINS | RIVER STONE BIOTECH APS (DK) | 2026-05-15 | — | — | WO | disclosed |
| US-20260078387-A1 | ENGINEERED BACTERIA, SYSTEMS, AND METHODS FOR DEGRADING POLYESTER MATERIALS | UNIV NORTHWESTERN (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | disclosed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | disclosed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250011804-A1 | INTERACTORS AND TARGETS FOR IMPROVING PLANT AGRONOMIC CHARACTERISTICS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-01-09 | — | — | US | disclosed |
| US-20100190244-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | YALE UNIVERSITY (US) | 2010-07-29 | — | — | US | disclosed |
| US-7751981-B2 | Articles of manufacture and methods for modeling Saccharomyces cerevisiae metabolism | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-07-06 | — | — | US | disclosed |
| US-20100041742-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | YALE UNIVERSITY (US) | 2010-02-18 | — | — | US | disclosed |
| EP-1546170-A2 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | Yale University (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20050053951-A1 | Riboswitches, methods for their use, and compositions for use with riboswitches | YALE UNIVERSITY | 2005-03-10 | — | — | US | disclosed |
| WO-2004027035-A2 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES. | YALE UNIVERSITY (US) | 2004-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050053951-A1 | Riboswitches, methods for their use, and compositions for use with riboswitches | NSUN3, RNGTT, SRRT | FDPS 203/4885P2RX7 3767/4885SORD 1928/4885 |
| US-20260078387-A1 | ENGINEERED BACTERIA, SYSTEMS, AND METHODS FOR DEGRADING POLYESTER MATERIALS | MRPL21, PGLS, CEL | FDPS 393/4885P2RX7 2213/4885SORD 1637/4885 |
| US-20100190244-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | NSUN3, RNGTT, SRRT | FDPS 199/4885P2RX7 3729/4885SORD 1892/4885 |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | AHCY, SHMT1, MTHFD1 | FDPS 5/4885P2RX7 4698/4885SORD 173/4885 |
| US-20100041742-A1 | RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES | NSUN3, RNGTT, SRRT | FDPS 203/4885P2RX7 3767/4885SORD 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.